Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4L pseudogene 24 (MTND4LP24) is a nomenclature proposal for a pseudogene related to MT-ND4L, the mitochondrially encoded core subunit 4L of NADH:ubiquinone oxidoreductase (complex I of the respiratory chain). The actual MT-ND4L gene is well characterized and encodes a critical subunit of complex I, facilitating electron transfer from NADH to ubiquinone and contributing to ATP synthesis[1][5][6]. Variants of the true MT-ND4L are implicated in diseases such as Leber hereditary optic neuropathy and metabolic syndrome[1][3][5][6]. However, pseudogenes like MTND4LP24 do not encode functional protein and are not considered targets for therapeutic intervention. No reputable database or research publication describes MT-ND4L pseudogene 24 as a valid molecular target or assigns it biological or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 24 (MTND4LP24).